CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to NVO

Phase 3

Development Phase

3

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q3 '27
NVOPhase 3

Cagrilintide Phase 3 Est. Readout (REDEFINE 3)

Cagrilintide
Q3 2027~Q
CT.gov
00%
Q2 '27
NVOPhase 3

Cagrilintide Phase 3 Est. Readout (RENEW 4)

Cagrilintide
Q2 2027~Q
CT.gov
00%
May '27
NVOPhase 3

Cagrilintide Phase 3 Est. Readout (RENEW 2)

Cagrilintide
May 2027~
CT.gov
00%
Competitive Landscape

1 competitor in Obesity or Overweight

View Full Landscape
Drug Information

Target Indication

Obesity or Overweight

Clinical Trial

NCT05813925

Last updated: 12/8/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.